Galux has signed a research agreement with Boehringer Ingelheim to jointly explore the application of AI in precision protein ...
Halo Pharma is expanding manufacturing capacity at its Whippany, NJ, facility with the addition of a Gerteis Macro-Pactor.
Exdensur is the first and only ultra-long-acting biologic for patients with severe asthma with an eosinophilic phenotype.
Harbour BioMed, a global biopharmaceutical company, has announced a multi-year, global strategic collaboration and license ...
MEDI&GENE, a biopharmaceutical company, has entered into a Catalyze agreement with Eli Lilly and Company to advance a ...
Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback